IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BANDERA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.149
NA - Nord America 18.818
AS - Asia 17.498
SA - Sud America 1.978
AF - Africa 519
OC - Oceania 143
Continente sconosciuto - Info sul continente non disponibili 10
Totale 60.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.893
IT - Italia 6.327
CN - Cina 5.102
SG - Singapore 5.050
DE - Germania 4.358
GB - Regno Unito 3.746
HK - Hong Kong 1.644
BR - Brasile 1.523
VN - Vietnam 1.467
BD - Bangladesh 1.358
RU - Federazione Russa 1.331
SE - Svezia 1.245
NL - Olanda 844
FR - Francia 828
IN - India 783
CA - Canada 661
FI - Finlandia 515
IE - Irlanda 494
ID - Indonesia 423
TR - Turchia 316
KR - Corea 288
ES - Italia 287
JP - Giappone 260
CI - Costa d'Avorio 178
UA - Ucraina 169
AR - Argentina 146
MX - Messico 143
PL - Polonia 141
AU - Australia 128
DK - Danimarca 128
AT - Austria 126
CH - Svizzera 122
IQ - Iraq 97
ZA - Sudafrica 91
BE - Belgio 90
TW - Taiwan 82
CO - Colombia 80
PH - Filippine 73
GR - Grecia 67
PK - Pakistan 60
SA - Arabia Saudita 54
CL - Cile 52
AE - Emirati Arabi Uniti 49
EC - Ecuador 49
RO - Romania 49
TH - Thailandia 49
MY - Malesia 46
VE - Venezuela 44
IR - Iran 43
MA - Marocco 43
EG - Egitto 36
UZ - Uzbekistan 36
CZ - Repubblica Ceca 32
JO - Giordania 31
PE - Perù 30
EU - Europa 28
KE - Kenya 28
NO - Norvegia 28
NP - Nepal 28
PT - Portogallo 26
HU - Ungheria 25
TN - Tunisia 25
LT - Lituania 24
IL - Israele 23
JM - Giamaica 23
PY - Paraguay 23
DZ - Algeria 22
CR - Costa Rica 20
LU - Lussemburgo 19
AZ - Azerbaigian 18
BG - Bulgaria 16
BO - Bolivia 16
KZ - Kazakistan 16
LB - Libano 16
RS - Serbia 16
SC - Seychelles 15
AL - Albania 14
ET - Etiopia 14
NG - Nigeria 13
NZ - Nuova Zelanda 13
PA - Panama 13
HR - Croazia 12
DO - Repubblica Dominicana 11
EE - Estonia 11
KG - Kirghizistan 11
MD - Moldavia 11
UY - Uruguay 11
BY - Bielorussia 10
HN - Honduras 10
SN - Senegal 10
GT - Guatemala 9
KW - Kuwait 9
OM - Oman 9
SI - Slovenia 9
GE - Georgia 7
GH - Ghana 7
MK - Macedonia 7
SV - El Salvador 7
AM - Armenia 6
KH - Cambogia 6
Totale 60.002
Salva come PNG Salva come JPEG
Città #
Southend 3.131
Singapore 2.792
Ashburn 2.474
Frankfurt am Main 1.702
Hanover 1.551
Dallas 1.455
Milan 1.448
Hong Kong 1.377
San Jose 1.094
Chandler 1.012
Council Bluffs 861
Beijing 749
Fairfield 713
Los Angeles 592
Hefei 512
New York 492
Dublin 476
Rome 457
Santa Clara 424
Princeton 402
Ho Chi Minh City 399
Seattle 392
Boardman 383
Hanoi 371
Wilmington 371
Houston 349
Helsinki 326
Jakarta 323
Toronto 313
Woodbridge 302
Cambridge 295
Lauterbourg 287
Bengaluru 284
Moscow 271
Buffalo 261
Ann Arbor 256
Guangzhou 240
Shanghai 222
Abidjan 177
São Paulo 171
Chicago 166
Seoul 157
Redwood City 149
Nanjing 146
The Dalles 146
Tokyo 146
Istanbul 145
Phoenix 144
Des Moines 142
Dearborn 140
Munich 137
Columbus 135
Nuremberg 132
Turin 122
Naples 119
Berlin 103
Cangzhou 102
Lappeenranta 96
Jacksonville 93
London 93
Dong Ket 92
Montreal 91
Atlanta 90
Warsaw 90
Boston 83
Genoa 83
Madrid 83
San Diego 77
Washington 76
Changsha 75
Bologna 74
Da Nang 74
Hangzhou 70
Amsterdam 65
Florence 64
Haiphong 64
Palermo 62
Vienna 62
Paris 61
Brussels 59
Central District 59
Chennai 59
Silver Spring 59
Shenzhen 58
Fuzhou 57
Orem 57
Tianjin 57
Brooklyn 55
Shenyang 55
Rio de Janeiro 53
Denver 52
Ottawa 52
Jinan 51
Pontedera 51
Redmond 51
Wuhan 51
Mountain View 50
Turku 48
Bühl 44
Grafing 44
Totale 34.878
Salva come PNG Salva come JPEG
Nome #
A second update on mapping the human genetic architecture of COVID-19 1.502
Mapping the human genetic architecture of COVID-19 1.148
Occupational HIV infection in a research laboratory with unknown mode of transmission : a case report 869
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 625
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 582
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 576
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 576
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples 506
Aumento del peso nelle persone che vivono con infezione da HIV: ritorno al benessere o effetto indesiderato della terapia antiretrovirale? = Weight gain in people living with HIV infection : return to health or adverse event of antiretroviral therapy? 435
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 410
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 407
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 393
Hospital Acquired Infections in COVID-19 patients in sub intensive care unit 391
The impact of SARS-CoV-2 VOCs on clinical outcomes: an overview of reviews 384
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals 374
Spoligotyping and mycobacterium tuberculosis 373
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 367
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 366
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 366
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 354
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 353
Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues : comparison of four amplifiaction assays 346
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient : case report and review of the literature 339
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults : results of the "COPA" pilot randomized trial 336
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 334
Qualitative immune modulation by Interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients 327
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 324
A PCR-colorimetric microwell plate hybridization assay for detection of Mycobacterium tuberculosis and M. avium from culture samples and Ziehl-Neelsen-positive smears 322
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 321
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 313
PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humans 312
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 311
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 310
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 306
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study 306
Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study 302
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 296
The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery 291
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 288
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 286
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 284
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 279
SARS-CoV-2-related atypical thyroiditis 278
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 278
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 268
Comparison between Spoligotyping and IS6110 Restriction Fragment Polymorphism in Molecular Genotyping Analysis of Mycobacterium tuberculosis strains 262
Enhancing care for people living with HIV: current and future monitoring approaches 262
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer 261
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID 260
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins 259
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 258
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen : worth the risk? 257
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 251
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 250
Genetic insight into Covid-19 related liver injury 249
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 247
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy? 246
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 245
Towards rapid sepsis diagnosis and patients stratification : What's new from microbiology and omics science 244
Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy 244
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 240
Monitoring of transmission of tuberculosis between wild boars and cattle : genotypical analysis of strains by molecular epidemiology techniques 236
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics 234
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol 233
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 233
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis 232
Mucormycosis in CAPA, a possible fungal super-infection 232
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 230
Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era 229
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 229
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 228
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 227
Neurocognitive impairment in HIV-infected naive patients with advanced disease: the role of virus and intrathecal immune activation 226
Nosocomial bacterial pneumonia in HIV-infected patients : risk factors for adverse outcome and implications for rational empiric antibiotic therapy 225
A case of Costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient 224
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting : data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 224
Genotyping analyses of tuberculosis transmission among immigrant residents in Italy 224
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy 223
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy 221
Multidrug‐resistant gram‐negative bacteria decolonization in immunocompromised patients : a focus on fecal microbiota transplantation 219
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 217
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy 216
Antiviral Treatments for Influenza 216
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 214
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy 213
Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years 212
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 212
A one health framework to estimate the cost of antimicrobial resistance 212
Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia : Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia 210
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 209
HIV-associated neurocognitive impairment in the modern ART era : are we close to discovering reliable biomarkers in the setting of virological suppression? 209
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature 209
SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals 209
Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19 207
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results 207
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 206
Inflammasome and Th17 activation in HIV+ immunological nonresponders 204
Inflammasome and Pyroptosis are Involved in The Lack of Immune Response During cART 204
Chromosomally integrated human herpesvirus 6 (ci-HHV-6) in autologous bone marrow transplant recipients: are we missing a reactivation or is it just mimicking? 203
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment 202
Totale 31.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 0 0 310
2021/20225.758 236 218 301 280 306 313 705 1.331 719 425 303 621
2022/20234.573 549 460 331 475 490 753 175 302 468 101 325 144
2023/20245.147 181 276 255 317 966 495 508 358 240 349 578 624
2024/202510.787 493 924 440 927 660 627 612 1.039 733 1.129 1.190 2.013
2025/202625.715 2.175 2.171 2.648 2.141 2.193 1.528 3.005 1.338 2.519 1.901 3.167 929
Totale 62.080